ClinicalTrials.gov
public full text
Public Domain
The KHENERGYC Study
This a randomized placebo controlled, double-blind phase II study to explore the pharmacokinetics, safety and efficacy of sonlicromanol in children (from birth to 17 years) with genetically confirmed mitochondrial disease of which the gene defect is known to decrease one or more oxidative phosphorylation system enzymes and who suffer from motor symptoms ("KHENERGYC").
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study on Pigmentation Disorders in Children#1228207
- Cascade counselling and testing. Recommendations of the European Society of Human Genetics#153597
- Radiological Analysis on Patients With Achondroplasia Disorder#831591
- The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease#892230
- Evaluation de la condition physique, de l’activité physique et du syndrome d'apnées du sommeil dans la trisomie 21 : quels déterminants et interactions ?#676934
Record · ID 1454502
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive